Clinical features, diagnosis and treatment of autoimmune pancreatitis
-
摘要: <正>自身免疫性胰腺炎(autoimmune pancreatitis,AIP)是一种良性、纤维炎症性慢性胰腺炎,有独特的临床、影像学及组织病理学特征,对糖皮质激素治疗应答良好。这种形式的慢性胰腺炎在1961年首先由Sarles[1]及其同事提出,当时认为此病是胰腺的原发性炎症性硬化性疾病。1995年,Yoshida等[2]将其定义为"自身免疫性胰腺炎"。在过去的十年间发现AIP患者血清中lgG4水平增高,炎性胰腺组织内lgG4阳性浆细胞增多[3]。后
-
Key words:
- pancreatitis /
- autoimmune diseases
-
[1]Sarles H, Sarles JC, Muratore R, et al.Chronic inflammatory scle-rosis of the pancreas:an autonomous pancreatic disease?[J].AmJ Dig Dis, 1961, 6∶688-698. [2]Yoshida K, Toki F, Takeuchi T, et al.Chronic pancreatitis causedby an autoimmune abnormality:proposal of the concept of autoim-mune pancreatitis[J].Dig Dis Sci, 1995, 40 (7) ∶1561-1568. [3]Kamisawa T, Okamoto A.Autoimmune pancreatitis:proposal ofIgG4-related sclerosing disease[J].J Gastroenterol, 2006, 41 (7) ∶613-625. [4]唐令诠, 冯昌宁, 蒋智敏.原发性自身免疫性胰腺炎一例报道并文献复习[J].胰腺病学, 2004, 4 (1) ∶41-42. [5]宋建功, 贾利敏, 李红燕, 等.慢性自身免疫性胰腺炎误诊1例并文献复习[J].临床消化杂志, 2007, 19 (2) ∶119-120. [6]刘兆云, 张春燕, 杨云生, 等.自身免疫性胰腺炎二例报道并文献复习[J].胰腺病学, 2007, 7 (5) ∶332-333. [7]霍红, 司雁菱.自身免疫性胰腺炎一例[J].中华胰腺病杂志, 2008, 8 (2) ∶91. [8] 吕红, 钱家鸣, 邓瑞雪, 等.自身免疫性胰腺炎的临床特点分析[C].中华医学会第八次全国消化疾病学术会议, 论文汇编.西安, 2008, 387-388.临床肝胆病杂志2010年第26卷第5期 [9]Chari ST, Smyrk TC, Levy MJ, et al.Diagnosis of autoimmunepancreatitis:the Mayo Clinic experience[J].Clin GastroenterolHepatol, 2006, 4 (8) ∶1010-1016. [10]Hamano H, Kawa S, Horiuchi A, et al.High serum IgG4 concen-trations in patients with sclerosing pancreatitis[J].N Engl J Med, 2001, 344 (10) ∶732-738. [11]Nishino T, Toki F, Oyama H, et al.Long-term outcome of auto-immune pancreatitis after oral prednisolone therapy[J].InternMed, 2006, 45 (8) ∶497-501. [12]Uchida K, Okazaki K, Asada M, et al.Case of chronic pancreatitisinvolving an autoimmune mechanism that extended to retroperitonealfibrosis[J].Pancreas, 2003, 26 (1) ∶92-94. [13]Okazaki K, Uchida K, Chiba T.Recent concept of autoimmune-related pancreatitis[J].J Gastroenterol, 2001, 36 (5) ∶293-302. [14]Asada M, Nishio A, Uchida K, et al.Identification of a novel au-toantibody against pancreatic secretory trypsin inhibitor in patientswith autoimmune pancreatitis[J].Pancreas, 2006, 33 (1) ∶20-26. [15]Irie H, Honda H, Baba S, et al.Autoimmune pancreatitis:CTandMR-characteristics.AJRAm[J].J Roentgenol, 1998, 170 (5) ∶1323-1327. [16]Members of the Criteria Committee for Autoimmune Pancreatitis ofthe Japan Pancreas Society.Diagnostic criteria for autoimmune pan-creatitis by the Japan Pancreas Society (in Japanese) [J].Suizou (J Japan Pancreas Society) , 2002, 17∶585-587. [17]Kamisawa T, Chen PY, Tu Y, et al.MRCP and MRI findings in 9patients with autoimmune pancreatitis[J].World J Gastroenterol, 2006, 12 (18) ∶2919-2922. [18]Klimstra DS, Adsay NV.Lymphoplasmacytic sclerosing (autoim-mune) pancreatitis[J].Semin Diagn Pathol, 2004, 21 (4) ∶237-246. [19]Okazaki K, Kawa S, Kamisawa T, et al.Clinical diagnostic criteriaof autoimmune pancreatitis:revised proposal[J].J Gastroenterol, 2006, 41 (7) ∶626-631. [20]Chari ST, Smyrk TC, Levy MJ, et al.Diagnosis of autoimmunepancreatitis:the MayoClinic experience[J].Clin GastroenterolHepatol, 2006, 4∶1010-1016. [21]SongY, Liu QD, Zhou NX, et al.Diagnosis and management of auto-immune pancreatitis:experience from China[J].World J Gastroen-terol, 2008, 14 (4) ∶601-606. [22]Park do H, Kim MH, Oh HB, et al.Substitution of aspartic acid atposition 57 of the DQβ1 affects relapse of autoimmune pancreatitis[J].Gastroenterology, 2008, 134 (2) ∶440-446. [23]Finkelberg DL, Sahani D, Deshpande V, et al.Autoimmune pan-creatitis[J].N Engl J Med, 2006, 355 (25) ∶2670-2676. [24]Kim KP, Kim MH, Song MH, et al.Autoimmune chronic pancrea-titis[J].Am J Gastroenterol, 2004, 99 (8) ∶1605-1616. [25]Padilla D, Cubo T, Villarejo P, et al.Response to steroid therapyof sclerosing cholangitis after duodenopancreatectomy due to autoim-mune pancreatitis[J].Gut, 2005, 54 (9) ∶1348-1349.
本文二维码
计量
- 文章访问数: 3633
- HTML全文浏览量: 14
- PDF下载量: 821
- 被引次数: 0